Securities / Derivatives

Market Infrastructure

HKEX Finalises Changes to Listing Regime for Overseas Issuers

By Manesh Samtani | 21/11/2021

From 1 January 2022, overseas issuers without WVR structures will have lower minimum market cap requirements to secondary list in Hong Kong.

Securities / Derivatives

China Banks Directed to Limit Proprietary Trading in Currencies

By Editors | 21/11/2021

The directions are part of efforts to limit speculation on the yuan to prevent further strengthening of the currency and protect the export sector.

Securities / Derivatives

SEBI Publishes Charter of Investor Rights in Securities Market

By Editors | 21/11/2021

The charter sets out the rights and responsibilities of investors, as well as some ‘dos and don’ts’ of investing in the securities market.

Securities / Derivatives

China Lifts Freeze on ABS Issuance by Property Developers

By Editors | 21/11/2021

Regulators reportedly plan to also relax restrictions on the size of new interbank bond issuance by “high quality” developers.

Market Infrastructure

SEBI Proposes Market Maker Framework for Corporate Bonds

By Sanday Chongo Kabange | 21/11/2021

To act as market makers, stockbrokers and merchant banks would need INR 100 million in additional net worth over-and-above their existing obligations.

Securities / Derivatives

SEBI Proposes to Tighten Rules on Use of IPO Proceeds

By Sanday Chongo Kabange | 19/11/2021

SEBI is considering increasing the lock-in period for anchor investors and limiting share sales by significant shareholders for six months.

Securities / Derivatives

Bursa Malaysia Announces New Initiative to Accelerate ESG Adoption

By Manesh Samtani | 18/11/2021

The initiative, known as #financing4ESG, will promote sustainable finance in Malaysia and accelerate ESG adoption among listed companies.

Securities / Derivatives

HK FSDC Proposes Measures to Advance Biotech Hub Ambitions

By Manesh Samtani | 18/11/2021

The FSDC says allowing SPACs to list in Hong Kong will help to bolster the city’s status as a fundraising hub for the healthcare and biotech sectors.

Securities / Derivatives

China Tightens Rules on Special Purpose Bonds, Use of Proceeds

By Darien Choong | 18/11/2021

SPB proceeds must be used strictly in accordance with the purposes disclosed in the prospectus. Any variations must be approved and properly disclosed.